Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes

Sunil B Kumaraswamy1, Adam Linder, Per Åkesson

  • 1Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Entrance 46, Malmö, SE-20502, Sweden.

Abstract

Insights

Plasma concentrations of apolipoprotein M (apoM) significantly decrease during sepsis and systemic inflammatory response syndrome (SIRS). Lower apoM levels correlate with disease severity, potentially contributing to vascular leakage.

Area of Science:

  • Biochemistry
  • Clinical Medicine
  • Immunology

Background:

  • Apolipoprotein M (apoM) is a protein found in high-density lipoprotein (HDL) particles.
  • It serves as a carrier for sphingosine-1-phosphate (S1P), crucial for maintaining vascular barrier integrity.
  • Understanding apoM levels in inflammatory conditions is vital for assessing disease progression and potential complications.

Purpose of the Study:

  • To quantify plasma concentrations of apoM in patients with sepsis and SIRS.
  • To investigate the correlation between apoM levels and other biomarkers such as apolipoprotein A-I (apoA1), apolipoprotein B (apoB), and cholesterol levels (HDL, LDL).
  • To determine if apoM acts as an acute-phase reactant in these conditions.

Main Methods:

  • Plasma samples were collected from distinct patient groups: severe sepsis with shock, severe sepsis without shock, sepsis, infections without SIRS, and SIRS without infection.
  • Concentrations of apoM, apoA1, and apoB were measured using enzyme-linked immunosorbent assays (ELISAs).
  • Total, HDL-, and LDL-cholesterol levels were determined using a commercial assay.

Main Results:

  • ApoM concentrations showed a negative correlation with acute-phase markers, indicating it functions as a negative acute-phase protein.
  • Significantly decreased apoM levels were observed across all patient groups compared to controls, with the most pronounced reduction in severe sepsis.
  • ApoM levels strongly correlated with apoA1, apoB, HDL-cholesterol, and LDL-cholesterol levels, which were also generally reduced in patient groups.

Conclusions:

  • Plasma apoM concentrations decrease dramatically during sepsis and SIRS, with the extent of reduction reflecting disease severity.
  • The diminished levels of apoM, a carrier of the vascular-protective S1P, may contribute to the increased vascular permeability characteristic of sepsis and SIRS.
  • ApoM's behavior as a negative acute-phase protein warrants further investigation in the context of inflammatory diseases.

Related Concept Videos

Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...